Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study

SIMPLE SUMMARY: Many people with skin cancer will have their cancer come back. The 31-gene expression profile (31-GEP) test can help predict if a cancer has a low (Class 1) or high (Class 2) chance of returning. This study looked at 86 patients with early skin cancer to see how well the 31-GEP test...

Descripción completa

Detalles Bibliográficos
Autores principales: Podlipnik, Sebastian, Boada, Aram, López-Estebaranz, Jose L., Martín-González, Manuel M., Redondo, Pedro, Martin, Brian, Quick, Ann P., Bailey, Christine N., Kurley, Sarah J., Cook, Robert W., Puig, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870692/
https://www.ncbi.nlm.nih.gov/pubmed/35205808
http://dx.doi.org/10.3390/cancers14041060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870692/
https://www.ncbi.nlm.nih.gov/pubmed/35205808
http://dx.doi.org/10.3390/cancers14041060

Ejemplares similares